BRIDGEWATER, N.J., Feb. 8, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced today that it will participate in the Leerink Swann Hot Topics in Therapeutics Roundtable Conference in New York City. Marc Beer, CEO of Aegerion, is scheduled to present on Wednesday, February 16, 2011, at 9:35 a.m. EST.
